Adbiotech Co., Ltd. (179530) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Adbiotech Co., Ltd. (179530:KRX), powered by AI.

Current Price
₩2,260
P/E Ratio
-18.4
Market Cap
60.9B
Sector
Healthcare
What is the Adbiotech Co., Ltd. stock price forecast?

Adbiotech Co., Ltd. is currently trading at ₩2,260. View real-time AI analysis on Alpha Lenz.

What is Adbiotech Co., Ltd. insider trading activity?

View the latest insider trading data for Adbiotech Co., Ltd. on Alpha Lenz.

What is Adbiotech Co., Ltd.'s P/E ratio?

Adbiotech Co., Ltd.'s P/E ratio is -18.4.

Adbiotech Co., Ltd.

KRX · 179530
₩2,260-55(-2.38%)Market closedKRX regular session 09:00–15:30 KST
Ask about Adbiotech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Adbiotech Co., Ltd. trades at a P/E of -18.4 (undervalued) with modest ROE of -32.8%.

Ask for details

Company Overview

Adbiotech Co., Ltd. is a prominent player in the biotechnology sector, specializing in the development and production of innovative products for animal health care. Primarily focused on advancing veterinary medicine, Adbiotech offers a diverse range of vaccines, diagnostic kits, and pharmaceutical formulations aimed at improving animal well-being and productivity. Their products cater to the needs of livestock, poultry, and domestic pets, ensuring robust health and disease prevention across these segments. Adbiotech operates in a critical industry that bridges agricultural productivity and public health, playing a vital role in maintaining the safety of animal-derived food products. The company's commitment to cutting-edge research and development has positioned it as a leader in animal biosciences. Through its activities, Adbiotech supports sectors such as agriculture and food production, emphasizing the importance of sustainable and safe practices. Within the financial market, it serves as a representation of the growing biotechnology field, attracting attention for its role in enhancing veterinary healthcare solutions and fostering advancements in biotechnology applications.

CEO정홍걸
SectorHealthcare
IndustryBiotechnology
Employees59

Company Statistics

FY 2025

Profile

₩60,907,675,740Market Cap
₩12,897,074,440Revenue
26.95MShares Out
59Employees

Margins

39.91%Gross
11.02%EBITDA
-27.14%Operating
-27.20%Pre-Tax
-25.81%Net

Valuation

-18.43P/E
3.97P/B
4.72EV/Sales
50.66EV/EBITDA
-35.91P/FCF

Growth (CAGR)

6.65%Rev 3Yr
5.61%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-9.31%ROA
-32.78%ROE
-4.74%ROIC

Financial Health

₩3,913,370,780Cash & Cash Equivalents
₩30,954,265,360Net Debt
257.52%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Adbiotech Co., Ltd. (ticker: 179530) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 59 employees. Market cap is $60.9B.

The current price is ₩2,260 with a P/E ratio of -18.43x and P/B of 3.97x.

ROE is -32.78% and operating margin is -27.14%. Annual revenue is $12.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Adbiotech Co., Ltd. (179530) Stock Forecast 2026 ₩2,260 — Price, Financials & Analyst Targets | Alpha Lenz